Inhibitors of gap junctions attenuate myogenic tone in cerebral arteries

被引:48
作者
Lagaud, G
Karicheti, V
Knot, HJ
Christ, GJ
Laher, I
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Inst Smooth Muscle Biol, Dept Urol, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA
[3] Univ British Columbia, Fac Med, Dept Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada
[4] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2002年 / 283卷 / 06期
关键词
heptanol; glycyrrhetinic acid; vascular smooth muscle; resistance arteries; vasopressin and depolarization;
D O I
10.1152/ajpheart.00605.2001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of two structurally distinct inhibitors of gap junction communication were studied by using three different forms of vasoconstriction in pressurized rat middle cerebral arteries. The sensitivity of myogenic tone (at 60 mmHg), vasopressin-induced tone (10 nM, at 20 mmHg), and depolarizing solution-induced tone (80 mM K+, at 20 mmHg) to inhibition by heptanol (1.0 muM to 3.0 mM) or 18alpha-glycyrrhetinic acid (18alpha-GA, 1.0 to 50 muM) were determined. Pressure-induced myogenic tone was inhibited by heptanol (IC50 = 0.75 +/- 0.09 mM) and 18alpha-GA (similar to30 muM). Vasopressin-induced vasoconstriction was also inhibited by heptanol (IC50 = 0.4 +/- 0.3 mM) and 18alpha-GA (>1 muM). Depolarizing solution-induced vasoconstriction was less sensitive to inhibition by heptanol compared to vasopressin (P < 0.01) or pressure-induced constriction (P < 0.05). However, 18alpha-GA did not inhibit depolarization-induced constriction. Sharp microelectrode experiments on isolated arteries revealed stable membrane potentials, with no detectable effect of heptanol (1 mM) or 18alpha-GA (20-30 muM) on the average membrane potential at 20 mmHg. However, approximate to20% of impaled cells (5 of 28) exhibited uncharacteristic oscillations in membrane potential after pharmacological uncoupling. At 60 mmHg a approximate to7- to 9-mV hyperpolarization and corresponding vasodilation (approximate to50%) was observed, and the frequency of membrane potential oscillations doubled (9 of 23 cells). These data indicate that gap junctions play an important role in the maintenance and modulation of membrane potential and tone in cerebral resistance arteries.
引用
收藏
页码:H2177 / H2186
页数:10
相关论文
共 48 条
[1]  
BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q
[2]   BIDIRECTIONAL ELECTRICAL COMMUNICATION BETWEEN SMOOTH-MUSCLE AND ENDOTHELIAL-CELLS IN THE PIG CORONARY-ARTERY [J].
BENY, JL ;
PACICCA, C .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :H1465-H1472
[3]   Peptide inhibitors of intercellular communication [J].
Berthoud, VM ;
Beyer, EC ;
Seul, KH .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 279 (04) :L619-L622
[4]   Biophysical characteristics of gap junctions in vascular wall cells: implications for vascular biology and disease [J].
Brink, PR ;
Ricotta, J ;
Christ, GJ .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2000, 33 (04) :415-422
[5]   The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication [J].
Chaytor, AT ;
Martin, PEM ;
Evans, WH ;
Randall, MD ;
Griffith, TM .
JOURNAL OF PHYSIOLOGY-LONDON, 1999, 520 (02) :539-550
[6]  
CHAYTOR AT, 1998, J PHYSL, V503, P99
[7]   Further evidence for the selective disruption of intercellular communication by heptanol [J].
Christ, GJ ;
Spektor, M ;
Brink, PR ;
Barr, L .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 276 (06) :H1911-H1917
[8]   INTERCELLULAR COMMUNICATION THROUGH GAP-JUNCTIONS - A POTENTIAL ROLE IN PHARMACOMECHANICAL COUPLING AND SYNCYTIAL TISSUE CONTRACTION IN VASCULAR SMOOTH-MUSCLE ISOLATED FROM THE HUMAN CORPUS CAVERNOSUM [J].
CHRIST, GJ ;
MORENO, AP ;
PARKER, ME ;
GONDRE, CM ;
VALCIC, M ;
MELMAN, A ;
SPRAY, DC .
LIFE SCIENCES, 1991, 49 (24) :PL195-PL200
[9]  
CHRIST GJ, 1993, J PHARMACOL EXP THER, V266, P1054